Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=139"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=139

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT01617096-sae",
        "title": "Dapivirine Vaginal Ring vs Placebo Ring: serious adverse events",
        "summary": "116 of 1313 against 130 of 1316; risk difference -1.0 points, 95% interval -3.3 to 1.2; NCT01617096, Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women",
        "record": "/library/comparisons/NCT01617096-sae",
        "nct_id": "NCT01617096",
        "kind": "serious-adverse-events",
        "participants": 2629,
        "risk_difference": {
          "value": -0.010436898260787031,
          "lower": -0.03280757597190066,
          "upper": 0.011899489113954904
        },
        "group_1": "116 of 1,313",
        "group_2": "130 of 1,316",
        "difference": "-1.0 points",
        "interval": "-3.3 to 1.2",
        "trial_title": "Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women"
      },
      {
        "id": "NCT01825200-1f66ded7",
        "title": "Flublok vs Afluria: Number of Participants With Local and Systemic Events Reported as a Measure of Safety",
        "summary": "432 of 1314 against 480 of 1313; risk difference -3.7 points, 95% interval -7.3 to -0.0; NCT01825200, Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age",
        "record": "/library/comparisons/NCT01825200-1f66ded7",
        "nct_id": "NCT01825200",
        "kind": "outcome",
        "participants": 2627,
        "risk_difference": {
          "value": -0.036807895752694386,
          "lower": -0.07308098148981187,
          "upper": -0.0003993828078791492
        },
        "group_1": "432 of 1,314",
        "group_2": "480 of 1,313",
        "difference": "-3.7 points",
        "interval": "-7.3 to -0.0",
        "trial_title": "Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=140",
  "request_id": "p5ScuiMIcHmTS6ya"
}